These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 19285517)

  • 1. Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR.
    Fricker AC; Mok MH; de la Flor R; Shah AJ; Woolley M; Dawson LA; Kew JN
    Neuropharmacology; 2009; 56(6-7):1060-7. PubMed ID: 19285517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.
    Lea PM; Wroblewska B; Sarvey JM; Neale JH
    J Neurophysiol; 2001 Mar; 85(3):1097-106. PubMed ID: 11247980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of NMDA receptors in regulating group II metabotropic glutamate receptor-mediated long-term depression in rat medial prefrontal cortex.
    Huang CC; Hsu KS
    Neuropharmacology; 2008 Jun; 54(7):1071-8. PubMed ID: 18378263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neurons.
    Losi G; Vicini S; Neale J
    Neuropharmacology; 2004 Mar; 46(4):490-6. PubMed ID: 14975672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
    Cartmell J; Adam G; Chaboz S; Henningsen R; Kemp JA; Klingelschmidt A; Metzler V; Monsma F; Schaffhauser H; Wichmann J; Mutel V
    Br J Pharmacol; 1998 Feb; 123(3):497-504. PubMed ID: 9504391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain.
    Shave E; Pliss L; Lawrance ML; FitzGibbon T; Stastny F; Balcar VJ
    Neurochem Int; 2001 Jan; 38(1):53-62. PubMed ID: 10913688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group II metabotropic glutamate receptors inhibit glutamate release at thalamocortical synapses in the developing somatosensory cortex.
    Mateo Z; Porter JT
    Neuroscience; 2007 May; 146(3):1062-72. PubMed ID: 17418955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses.
    Macek TA; Winder DG; Gereau RW; Ladd CO; Conn PJ
    J Neurophysiol; 1996 Dec; 76(6):3798-806. PubMed ID: 8985877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG).
    Romei C; Raiteri M; Raiteri L
    Neuropharmacology; 2013 Mar; 66():311-6. PubMed ID: 22659408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabotropic glutamate receptor mGluR3 is critically required for hippocampal long-term depression and modulates long-term potentiation in the dentate gyrus of freely moving rats.
    Pöschel B; Wroblewska B; Heinemann U; Manahan-Vaughan D
    Cereb Cortex; 2005 Sep; 15(9):1414-23. PubMed ID: 15635057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model.
    Adedoyin MO; Vicini S; Neale JH
    Mol Pain; 2010 Sep; 6():60. PubMed ID: 20860833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells.
    Wroblewska B; Wroblewski JT; Pshenichkin S; Surin A; Sullivan SE; Neale JH
    J Neurochem; 1997 Jul; 69(1):174-81. PubMed ID: 9202308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes.
    Wroblewska B; Santi MR; Neale JH
    Glia; 1998 Oct; 24(2):172-9. PubMed ID: 9728763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin.
    Thomas AG; Vornov JJ; Olkowski JL; Merion AT; Slusher BS
    J Pharmacol Exp Ther; 2000 Oct; 295(1):16-22. PubMed ID: 10991955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes.
    Wroblewska B; Wegorzewska IN; Bzdega T; Olszewski RT; Neale JH
    J Neurochem; 2006 Feb; 96(4):1071-7. PubMed ID: 16417588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous N-acetylaspartylglutamate reduced NMDA receptor-dependent current neurotransmission in the CA1 area of the hippocampus.
    Bergeron R; Imamura Y; Frangioni JV; Greene RW; Coyle JT
    J Neurochem; 2007 Jan; 100(2):346-57. PubMed ID: 17241157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroactive peptide N-acetylaspartylglutamate is not an agonist at the metabotropic glutamate receptor subtype 3 of metabotropic glutamate receptor.
    Chopra M; Yao Y; Blake TJ; Hampson DR; Johnson EC
    J Pharmacol Exp Ther; 2009 Jul; 330(1):212-9. PubMed ID: 19389924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance.
    Zhao J; Ramadan E; Cappiello M; Wroblewska B; Bzdega T; Neale JH
    Eur J Neurosci; 2001 Jan; 13(2):340-6. PubMed ID: 11168538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons.
    Bergeron R; Coyle JT; Tsai G; Greene RW
    Neuropsychopharmacology; 2005 Jan; 30(1):7-16. PubMed ID: 15354184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group II mGluR-induced long term depression in the dentate gyrus in vivo is NMDA receptor-independent and does not require protein synthesis.
    Pöschel B; Manahan-Vaughan D
    Neuropharmacology; 2005; 49 Suppl 1():1-12. PubMed ID: 16084931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.